{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:22:15Z","timestamp":1789215735394,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HV22C0069"],"award-info":[{"award-number":["HV22C0069"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-00258617"],"award-info":[{"award-number":["RS-2023-00258617"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.imlet.2024.106924","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:58:18Z","timestamp":1726127898000},"page":"106924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["IL-21 drives skin and lung inflammation and fibrosis in a model for systemic sclerosis"],"prefix":"10.1016","volume":"270","author":[{"given":"In Gyu","family":"Um","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Yeon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Sik","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Su","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung- Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imlet.2024.106924_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102730","article-title":"Targeted delivery in scleroderma fibrosis","volume":"20","author":"Varrica","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.imlet.2024.106924_bib0002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.imlet.2024.106924_bib0003","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106924_bib0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"5","key":"10.1016\/j.imlet.2024.106924_bib0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.1780330507","article-title":"Secretion and binding of transforming growth factor beta by scleroderma and normal dermal fibroblasts","volume":"33","author":"Needleman","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2024.106924_bib0006","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.imbio.2015.09.021","article-title":"Biological effects of IL-21 on different immune cells and its role in autoimmune diseases","volume":"221","author":"Gharibi","year":"2016","journal-title":"Immunobiology"},{"issue":"3\u20134","key":"10.1016\/j.imlet.2024.106924_bib0007","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cytogfr.2007.04.003","article-title":"Interleukin-21: a new modulator of immunity, infection, and cancer","volume":"18","author":"Brandt","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.imlet.2024.106924_bib0008","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/annrheumdis-2012-202357","article-title":"Implication of IL-2\/IL-21 region in systemic sclerosis genetic susceptibility","volume":"72","author":"Diaz-Gallo","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2024.106924_bib0009","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"23","key":"10.1016\/j.imlet.2024.106924_bib0010","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1111\/jcmm.15266","article-title":"IFN-gamma(+) IL-17(+) Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma","volume":"24","author":"Xing","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.imlet.2024.106924_bib0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/reum.2019.87619","article-title":"Systemic sclerosis - multidisciplinary disease: clinical features and treatment","volume":"57","author":"Sobolewski","year":"2019","journal-title":"Reumatologia"},{"issue":"2","key":"10.1016\/j.imlet.2024.106924_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020154","article-title":"The treatment of lung involvement in systemic sclerosis","volume":"14","author":"Ruaro","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"10.1016\/j.imlet.2024.106924_bib0013","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24676","article-title":"G. canadian scleroderma research, Health-related quality of life in systemic sclerosis: a systematic review","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.imlet.2024.106924_bib0014","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gut.2006.093187","article-title":"Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21","volume":"55","author":"Monteleone","year":"2006","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.imlet.2024.106924_bib0015","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Nikitorowicz-Buniak","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106924_bib0016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rdc.2007.11.002","article-title":"Fibrosis in systemic sclerosis","volume":"34","author":"Varga","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.imlet.2024.106924_bib0017","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1513\/pats.200708-146DR","article-title":"Biology of fibroblasts and myofibroblasts","volume":"5","author":"Phan","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.imlet.2024.106924_bib0018","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","article-title":"Pathogenesis of fibrosis: role of TGF-beta and CTGF","volume":"14","author":"Ihn","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2024.106924_bib0019","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrrheum.2017.190","article-title":"Systemic sclerosis: STAT3 - A key integrator of profibrotic signalling","volume":"13","author":"McHugh","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2024.106924_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of IL-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.imlet.2024.106924_bib0021","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.it.2016.06.001","article-title":"IL-21 and T cell differentiation: consider the context","volume":"37","author":"Tian","year":"2016","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106924_bib0022","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.169.7.3600","article-title":"IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response","volume":"169","author":"Strengell","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.imlet.2024.106924_bib0023","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1084\/jem.20161791","article-title":"Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure","volume":"214","author":"Nevers","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.imlet.2024.106924_bib0024","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.20020620","article-title":"Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells","volume":"196","author":"Wurster","year":"2002","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.imlet.2024.106924_bib0025","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI27727","article-title":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation","volume":"116","author":"Pesce","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.imlet.2024.106924_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250075","article-title":"Interleukin-21 in autoimmune and inflammatory skin diseases","volume":"53","author":"Mesas-Fernandez","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"7152","key":"10.1016\/j.imlet.2024.106924_bib0027","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.imlet.2024.106924_bib0028","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2024.106924_bib0029","first-page":"14","article-title":"Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis","volume":"34","author":"Lei","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106924_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/path.4430","article-title":"IL-17A produced by both gammadelta T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction","volume":"235","author":"Peng","year":"2015","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.imlet.2024.106924_bib0031","doi-asserted-by":"crossref","first-page":"e23185","DOI":"10.1371\/journal.pone.0023185","article-title":"IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis","volume":"6","author":"Gasse","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.imlet.2024.106924_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.imlet.2024.106924_bib0033","doi-asserted-by":"crossref","first-page":"e13537","DOI":"10.1111\/apha.13537","article-title":"Th17\/Treg imbalance modulates rat myocardial fibrosis and heart failure by regulating LOX expression","volume":"230","author":"Lu","year":"2020","journal-title":"Acta Physiol. (Oxf.)"},{"issue":"6","key":"10.1016\/j.imlet.2024.106924_bib0034","doi-asserted-by":"crossref","first-page":"e39307","DOI":"10.1371\/journal.pone.0039307","article-title":"Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.imlet.2024.106924_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2024.106924_bib0036","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/14712598.2023.2196009","article-title":"Advances in biological and targeted therapies for systemic sclerosis","volume":"23","author":"Mulcaire-Jones","year":"2023","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.imlet.2024.106924_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102689","article-title":"New developments implicating IL-21 in autoimmune disease","volume":"122","author":"Ren","year":"2021","journal-title":"J. Autoimmun."},{"issue":"13","key":"10.1016\/j.imlet.2024.106924_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134527","article-title":"A JAK inhibitor for treatment of rheumatoid arthritis: the baricitinib experience","volume":"12","author":"Taylor","year":"2023","journal-title":"J. Clin. Med."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:47:05Z","timestamp":1733446025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"alternative-id":["S0165247824000981"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106924","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-21 drives skin and lung inflammation and fibrosis in a model for systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"106924"}}